XML 70 R60.htm IDEA: XBRL DOCUMENT v3.21.2
FAIR VALUE MEASUREMENTS - Narrative (Details)
$ in Thousands
Sep. 30, 2021
USD ($)
Dec. 31, 2020
USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Contingent consideration $ 363,647 $ 2,477
Product Development and Other Milestone-based Payments | Weighted Average | Measurement Input, Probability of Success    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Contingent consideration liability, measurement input 0.905  
Product Development and Other Milestone-based Payments | Weighted Average | Measurement Input, Present-value Factor    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Contingent consideration liability, measurement input 0.020  
Foreign Exchange Forward    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Derivative, notional amount $ 29,500 22,400
Level 3 | Fair Value, Nonrecurring    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Investment owned, at fair value 22,700 $ 29,100
Thrive and Ashion | Fair Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Contingent consideration 361,300  
Biomatrica, Inc | Revenue and Other Performance-based Payments    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Contingent consideration $ 2,300